Pharma/Biopharma

Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College announced Oct. 1 that they have formed the pioneering Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI) and have partnered with Takeda Pharmaceutical Company, Ltd. (TSE:4502).
| 5 min read

Highlighting an important but unexplored area of evolution, scientists at The Scripps Research Institute (TSRI) have found evidence that, over hundreds of millions of years, an essential protein has evolved chiefly by changing how it moves, rather than by changing its basic molecular structure.
| 3 min read

Biologists at the University of California, San Diego have developed a revolutionary new method for identifying and characterizing antibiotics, an advance that could lead to the discovery of new antibiotics to treat antibiotic resistant bacteria.
| 4 min read

Imagine being able to redirect powerful immune cells to fight cancer. How about reprogramming a diabetic’s skin cell into a cell that could manufacture the insulin their pancreas no longer produces? Could we dial down the production of fat cells in obese adolescents? These are major health problems and medical challenges that may be more achievable with a new fundamental technology that gets vital control molecules into cells faster, safer, and more effectively.
| 4 min read

Through research, testing, care, and education, The University of Texas MD Anderson Cancer Center, located in Houston, Texas, takes an integrative approach to cancer. We speak with Pramila Sood, lab administrator for the Department of Laboratory Medicine, about the unique management issues at the Center.
| 5+ min read










